EcoDrugPlus

Complement Component 5

Ensembl ID : ENSORLG00000017552
Gene Symbol: C5
3 Cross references
216 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSORLG00000000317
Gene Symbol: CCND1
4 Cross references
231 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSORLG00000019266
Gene Symbol: CDK1
3 Cross references
247 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSORLG00000014972
Gene Symbol: CDK2
4 Cross references
202 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSORLG00000015209
Gene Symbol: CDK4
4 Cross references
238 Possible Orthologues:

Cyclin-Dependent Kinase 5

Ensembl ID : ENSORLG00000017539
Gene Symbol: CDK5
4 Cross references
169 Possible Orthologues:

Cyclin-Dependent Kinase 6

Ensembl ID : ENSORLG00000004090
Gene Symbol: CDK6
4 Cross references
200 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSORLG00000008836
Gene Symbol: CDK7
4 Cross references
218 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSORLG00000018273
Gene Symbol: CDK9
4 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSORLG00000010305
Gene Symbol: CYSLTR1
4 Cross references
172 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSORLG00000027661
Gene Symbol: CDA
4 Cross references
200 Possible Orthologues:

Cytochrome P-450 17alpha-Hydroxylase/c17,20-Lyase

Ensembl ID : ENSORLG00000019226
Gene Symbol: CYP17
3 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).